Abstract
To assess B-cell function in patients under immunoglobulin (IgG)-replacement therapy, the non-licensed artificial bacteriophage (ΦX174)-neo-antigen may be used despite limited availability and experience. Active immunization against tick-borne encephalitis (TBE) is performed in few European countries. To test the feasibility of using licensed TBE vaccination as (neo-)antigen to determine residual or restored B-cell function in patients under regular IgG substitution, TBE-IgG levels were analyzed in 18 patients with ≥ 1-2 years of regular intravenous or subcutaneous IgG substitution and in pharmaceutical IgG-preparations (n=21 batches, 10 products). Six individuals were boosted against TBE. Although TBE-specific IgG was detectable in concentrates (281-57,100 VieU/0.5 μL), levels were only borderline in patient sera (n=31, 18 individuals; median 132 VieU; positive >155). Thus, TBE vaccination may be used to test B-cell function under IgG replacement therapy because IgG substitution appears insufficient to yield protective TBE-specific antibody levels in children.
References
May 1, 1989·Clinical Immunology and Immunopathology·K H PyunC B Reimer
Dec 1, 1971·The Journal of Clinical Investigation·H D OchsR J Wedgwood
Jan 1, 1981·American Journal of Hematology·K C DoneyE D Thomas
Dec 1, 1996·The Journal of Pediatrics·G LackE W Gelfand
Feb 14, 2003·Lancet·Arthur R BradwellMark T Drayson
Mar 11, 2003·Clinical and Diagnostic Laboratory Immunology·Uwe SchauerWilhelm Herzog
Mar 12, 2003·Vaccine·Christian Kunz
Oct 30, 2003·Viral Immunology·I GomezB Grubeck-Loebenstein
Nov 15, 2003·Vaccine·Hartmut J EhrlichP Noel Barrett
Jul 13, 2004·Vaccine·P Rendi-WagnerH Kollaritsch
Oct 12, 2005·Journal of Pediatric Hematology/oncology·Markus G SeidelChristina Peters
Apr 21, 2006·Vaccine·A Loew-BaselliUNKNOWN FSME-IMMUN study group
Aug 2, 2006·Clinical and Experimental Immunology·E de Vries, UNKNOWN Clinical Working Party of the European Society for Immunodeficiencies (ESID)
Sep 16, 2006·Journal of Virology·Karin StiasnyFranz X Heinz
Jun 9, 2007·Vaccine·Pamela Rendi-WagnerHerwig Kollaritsch
Jun 29, 2007·The Journal of Infectious Diseases·Christina B PlanitzerThomas R Kreil
Jan 8, 2008·Vaccine·Martina PrelogReinhard Wuerzner
Jan 9, 2008·The Journal of Infectious Diseases·Elin KindbergLennart Svensson
Apr 22, 2008·Immunology and Allergy Clinics of North America·Melvin Berger
Oct 23, 2008·Immunology and Allergy Clinics of North America·Martha M Eibl
Jan 20, 2009·Annals of Clinical Biochemistry·P Wood
Aug 8, 2009·Vox Sanguinis·M Radosevich, T Burnouf
Aug 18, 2009·The Journal of Allergy and Clinical Immunology·Ellen D RennerHans D Ochs
Sep 10, 2009·Clinical and Experimental Immunology·S HeidtA Mulder
Oct 1, 2009·Vaccine·Karin StiasnyFranz X Heinz
Feb 8, 2013·Journal of Immunological Methods·John P CampbellMark T Drayson
Citations
May 20, 2011·The Journal of Infectious Diseases·Klaus K OrlingerThomas R Kreil
Aug 31, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Mark Ballow
Jan 1, 2013·The Journal of Allergy and Clinical Immunology·Markus G SeidelElisabeth Förster-Waldl
Jan 1, 2013·The Journal of Allergy and Clinical Immunology·Jordan S Orange, Rohit Katial
Aug 1, 2012·The Journal of Allergy and Clinical Immunology·Roshini S Abraham
Apr 9, 2011·Vaccine·Zita ChovancovaVojtech Thon
Feb 24, 2015·Frontiers in Immunology·Hermann M WolfMartha M Eibl
Jan 21, 2015·Frontiers in Immunology·Sigune GoldackerKlaus Warnatz
Aug 1, 2018·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Mar 2, 2012·Clinical and Vaccine Immunology : CVI·Philip O RabelThomas R Kreil